Related Experiment Videos
Adenoviral vectors for gene replacement therapy
Huibi Cao1, David R Koehler, Jim Hu
1Programme in Lung Biology Research and the Canadian Institutes of Health Research Group in Lung Development, Hospital for Sick Children, Toronto, Canada.
Viral Immunology
|September 11, 2004
Summary
Adenovirus vectors show promise for gene replacement therapy by efficiently delivering genes to various cells. However, host immune responses remain a key challenge, though new designs are improving their clinical potential.
Area of Science:
- Gene Therapy
- Virology
- Immunology
Background:
- Adenovirus vectors are effective for gene delivery across diverse cell types.
- Two main categories exist: partially deleted (first/second-generation) and completely deleted (helper-dependent) vectors.
- Clinical applications face hurdles, primarily concerning host immune responses.
Purpose of the Study:
- To review the development and application of adenovirus vectors in gene therapy.
- To identify and discuss the challenges associated with adenovirus vector use.
- To highlight recent advancements improving adenovirus vector efficacy.
Main Methods:
- Classification of adenovirus vectors into distinct generations based on genetic modification.
- Review of preclinical and clinical studies involving adenovirus vectors.
- Analysis of host immune responses to adenovirus vectors.
Main Results:
- Adenovirus vectors efficiently transduce both dividing and non-dividing cells.
- Host immune responses (innate and adaptive) limit therapeutic efficacy and re-administration.
- Newer vector designs and delivery strategies are emerging to overcome these limitations.
Conclusions:
- Adenovirus vectors are potent tools for gene replacement therapy.
- Managing host immune responses is critical for successful clinical translation.
- Ongoing research in vector engineering enhances the therapeutic prospects of adenoviral gene therapy.